-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
NOF Names Schargorodski Executive Director
Washington, DC (August 25, 2006) – The National Osteoporosis Foundation (NOF) has named Leo Schargorodski as Executive Director. Mr. Schargorodski will officially begin his duties on September 18.
Mr. Schargorodski has more than thirty years experience in the not-for-profit, charitable, association and foundation fields. Immediately prior to joining NOF, Mr. Schargorodski served as Executive Director of the American Nurses Foundation and Chief Development Officer for the American Nurses Association, a position he held since 1998. His previous voluntary health agency experience includes working for such organizations as the American Diabetes Association and the March of Dimes Birth Defects Foundation. Mr. Schargorodski’s background includes a focus in the areas of fundraising, strategic and operation planning, grant solicitation, marketing and fiscal management.
“The Board is pleased to welcome Leo to the NOF team,” says the Hon. Daniel A Mica, Chairman of the Board of Trustees. His background and experience will be valuable assets in building on NOF’s strong record of achievements and leading it to an even stronger, more vital future. With more than 44 million Americans, aged 50 and older, either with or at risk for osteoporosis, the role of NOF has never been more critical.”
Mr. Schargorodski’s predecessor, Judith Cranford, resigned earlier this year effective August 31st. The Board of Trustees recognized her invaluable contributions in steering the organization over the last five years and thanked her for her significant accomplishments in advancing NOF’s cause.
Established in 1984, NOF is the nation’s leading voluntary health organization solely focused on osteoporosis and bone health.
The Foundation’s mission is to prevent osteoporosis, to promote life-long bone health, to help improve the lives of those affected by osteoporosis and related fractures and to find a cure. NOF achieves its mission through programs of awareness, advocacy, public and health professional education and research.
NOF retained the firm of Kensington International to conduct the search.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
